Table 2 Inclusion and exclusion criteria
Inclusion | Exclusion | |
|---|---|---|
Study Design | Randomised controlled trials | Non-randomised study design |
Population | Prescribers in secondary care setting | Prescribers outside of secondary care prescribers e.g. primary care doctors |
Setting/ Context | Secondary care | Community pharmacies GPs, care homes, palliative care, community care |
Target behaviour | Prescribing therapeutic drugs | Screening, monitoring, surgery behaviours, prescriptions of supplements, prescriptions of other non-therapeutic drugs |
Intervention | Any behavioural intervention used to de-implement low-value prescribing practices, including removal, reduction, replacement, or restriction of practice | Strategies not targeting prescribing behaviour, strategies aiming to increase prescribing rate, strategies targeting patients, strategies using diagnostic testing, use of tests to diagnose and strategies used in medical reviews |
Comparator(s)/ control | Usual practice, another intervention or waitlist | No comparator group |
Primary Outcomes | Change in prescribing including removal, reduction, replacement, or restriction of practice | Studies only reporting patient-related outcomes and not reporting clinical behaviour outcomes |
Secondary Outcomes | Patient-related outcomes (e.g. disease recurrence, adverse events) | None |
Geographical Locations | All | None |
Language | English | Not English |